Statin use and its effect on all‐cause mortality of melanoma patients: a population‐based Dutch cohort study

Abstract Preclinical data showed anticancer effects of statins in melanoma, but meta‐analyses could not demonstrate a reduced melanoma incidence in statin users. Rather than preventing occurrence, statins might reduce growth and metastatic spread of melanomas and ultimately improve survival. In this population‐based study, we investigated the relationship between statin use and survival of melanoma patients. Patients ≥18 years who were diagnosed with cutaneous melanoma (Breslow thickness >1 mm) and registered in the Eindhoven Cancer Registry and in PHARMO Database Network between 1 January... Mehr ...